INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Reckitt Benckiser Group plc - RBGLY
Werte in diesem Artikel
NEW YORK, Feb. 4, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Reckitt Benckiser Group plc ("Reckitt" or the "Company") (OTCMKTS:RBGLY). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.
The investigation concerns whether Reckitt and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.
[Click here for information about joining the class action]
On March 15, 2024, an Illinois jury returned a $60 million verdict against Reckitt in a lawsuit finding that Reckitt's Mead Johnson Nutrition unit failed to adequately disclose the risks of necrotizing enterocolitis in its cow-milk-based Enfamil baby formula. Following the verdict, Reckitt's American depositary receipt ("ADR") price fell $1.87 per ADR, or 14.05%, to close at $11.44 per ADR on March 15, 2024.
Pomerantz LLP, with offices in New York, Chicago, Los Angeles, London, Paris, and Tel Aviv, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions. Today, more than 85 years later, Pomerantz continues in the tradition he established, fighting for the rights of the victims of securities fraud, breaches of fiduciary duty, and corporate misconduct. The Firm has recovered numerous multimillion-dollar damages awards on behalf of class members. See www.pomlaw.com.
Attorney advertising. Prior results do not guarantee similar outcomes.
CONTACT:
Danielle Peyton
Pomerantz LLP
dpeyton@pomlaw.com
646-581-9980 ext. 7980
View original content to download multimedia:https://www.prnewswire.com/news-releases/investor-alert-pomerantz-law-firm-investigates-claims-on-behalf-of-investors-of-reckitt-benckiser-group-plc---rbgly-302368183.html
SOURCE Pomerantz LLP
Ausgewählte Hebelprodukte auf Reckitt Benckiser
Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf Reckitt Benckiser
Der Hebel muss zwischen 2 und 20 liegen
Name | Hebel | KO | Emittent |
---|
Name | Hebel | KO | Emittent |
---|
Nachrichten zu Reckitt Benckiser Plc
Analysen zu Reckitt Benckiser Plc
Datum | Rating | Analyst | |
---|---|---|---|
05.02.2025 | Reckitt Benckiser Market-Perform | Bernstein Research | |
04.02.2025 | Reckitt Benckiser Equal Weight | Barclays Capital | |
03.02.2025 | Reckitt Benckiser Neutral | JP Morgan Chase & Co. | |
03.02.2025 | Reckitt Benckiser Buy | UBS AG | |
24.01.2025 | Reckitt Benckiser Outperform | RBC Capital Markets |
Datum | Rating | Analyst | |
---|---|---|---|
03.02.2025 | Reckitt Benckiser Buy | UBS AG | |
24.01.2025 | Reckitt Benckiser Outperform | RBC Capital Markets | |
09.12.2024 | Reckitt Benckiser Outperform | RBC Capital Markets | |
01.11.2024 | Reckitt Benckiser Outperform | RBC Capital Markets | |
18.09.2024 | Reckitt Benckiser Buy | UBS AG |
Datum | Rating | Analyst | |
---|---|---|---|
05.02.2025 | Reckitt Benckiser Market-Perform | Bernstein Research | |
04.02.2025 | Reckitt Benckiser Equal Weight | Barclays Capital | |
03.02.2025 | Reckitt Benckiser Neutral | JP Morgan Chase & Co. | |
23.01.2025 | Reckitt Benckiser Neutral | JP Morgan Chase & Co. | |
08.01.2025 | Reckitt Benckiser Market-Perform | Bernstein Research |
Datum | Rating | Analyst | |
---|---|---|---|
27.03.2024 | Reckitt Benckiser Underperform | Jefferies & Company Inc. | |
19.03.2024 | Reckitt Benckiser Underperform | Jefferies & Company Inc. | |
18.03.2024 | Reckitt Benckiser Underperform | Jefferies & Company Inc. | |
28.02.2024 | Reckitt Benckiser Underperform | Jefferies & Company Inc. | |
22.02.2024 | Reckitt Benckiser Underperform | Jefferies & Company Inc. |
Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Reckitt Benckiser Plc nach folgenden Kriterien zu filtern.
Alle: Alle Empfehlungen